EUVIMED · CrossrefZeitschrift
Circulation: Heart Failure
ISSN 1941-3289 · Ovid Technologies (Wolters Kluwer Health)
Neueste Artikel
Recognition Requires Nomination: The People Who Make Excellence Visible
A Multicenter Randomized Controlled Trial of a Digital Health Intervention for Medication Optimization in Heart Failure: The ENGAGE-HF Trial Outcomes
Multiomics Integration Reveals a Skeletal Muscle Metabolic Myopathy in Cardiometabolic HFpEF
Heart Failure Presenting With Concurrent Chylothorax and Chylous Ascites Resolved by Revascularization in Ischemic Cardiomyopathy: A Case Report and Review
Exercise Right Atrial Stiffness From Pressure-Volume Loops and Prognosis in Pulmonary Hypertension
Antecedent Kidney Function and Cardiovascular Mortality in Over 300 000 Patients With Incident Heart Failure With Preserved Ejection Fraction
Left Atrial Remodeling and Functional Maladaptations in Obesity: An Invasive Pressure-Volume Analysis
Sex Differences in Skeletal Muscle Inflammation and Dysfunction in Patients With Heart Failure and Reduced Ejection Fraction
MRAs and Race in Heart Failure: An Individual Participant Data Meta-Analysis of Randomized Trials
Fetal Cardiomyopathy in the Contemporary Era: A Multicenter Fetal Heart Society Research Collaborative Study
Big Data and Trustworthy AI for Heart Failure: A Review
Short-Term Effects of Ambient Temperature on Acute Heart Failure Decompensation: Phenotype-Specific Risk in a Time-Stratified Case-Crossover Study
Right Ventricular Contractile Reserve in Heart Failure With Preserved Ejection Fraction
Rationale and Design of CARDIO-TTRansform, a Phase 3 Trial of Eplontersen in Transthyretin Amyloid Cardiomyopathy
Mechanisms of GLP-1 Receptor Agonists in HFpEF: Exploring Weight-Dependent and Independent Drivers of Therapeutic Benefit
Exploring Medication Adherence in Heart Failure From a Patient Perspective: A Qualitative Study
Mitigating Risk of Kidney Dysfunction After Heart Transplantation and Therapeutic Approaches
Simtuzumab Attenuates Loxl2-Mediated Extracellular Matrix Remodeling and Preserves Cardiac Function in LMNA Mutation-Induced Dilated Cardiomyopathy
Artificial Intelligence-Enabled ECG Analysis to Predict Incident Heart Failure
Cellular Interactions and Immunometabolic Mechanisms in Heart Failure With Preserved Ejection Fraction: From Molecular Mechanisms to Clinical Evidence
Resolution of Systemic Inflammation in Patients With Recently Decompensated Heart Failure With Reduced Ejection Fraction With and Without Interleukin-1 Blockade by Anakinra
Tribulations of Randomized Controlled Trials: Testing the Inflammatory Hypothesis of Heart Failure
Correction to: Standardization of Baseline and Provocative Invasive Hemodynamic Protocols for the Evaluation of Heart Failure and Pulmonary Hypertension: A Scientific Statement From the American Heart Association
Digital Platform to Optimize Guideline-Directed Heart Failure Therapy: Results of the AIM-POWER Trial
Standardization of Baseline and Provocative Invasive Hemodynamic Protocols for the Evaluation of Heart Failure and Pulmonary Hypertension: A Scientific Statement From the American Heart Association
Air Pollution and Exposomic Impacts on Heart Failure
Prevalence and Clinical Implications of Excess Adiposity in Group 1 Pulmonary Hypertension
Global Proteoform Alterations Across Multiple Cellular Compartments Underlie Obstructive Hypertrophic Cardiomyopathy
Survival Odds to Minimize Risk Heterogeneity Bias in Heart Failure Trials: Application to Dapagliflozin
TAPSE/sPAP Ratio to Improve Risk Assessment in Pulmonary Arterial Hypertension
EUVIMED